Learning Objectives
At the conclusion of this activity, the participants should be able to:

• Describe the mechanism of action for key novel supportive care medications
• Review safety and efficacy data for novel supportive care medications
• Identify opportunities for integration of novel medications into clinical workflow

Bio:

Cassia Griswold is a Clinical Pharmacist in the Department of Hematology/Oncology at Mayo Clinic here in Phoenix, AZ. She attended pharmacy school at the University of Arizona College of Pharmacy, subsequently completing a PGY-1 residency at Swedish Medical Center and a PGY-2 at the University of Utah/Huntsman Cancer Institute. She has worked in a variety of solid tumor clinics and currently specializes in genitourinary malignancies. She also serves as a panel member on the NCCN Antiemesis guidelines.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.